QUILLIVANT

What this means for you

Registered since 27 Aug 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Aug 2023).

Record

Serial number

85332659

Registration number

4392798

Mark type

Stylized text

Filed

27 May 2011

Published for opposition

01 Nov 2011

Registered

27 Aug 2013

Next maintenance due

27 Aug 2023

Attorney of record

Cathy A. Kodroff

Goods and services

• Class 005 — Pharmaceuticals: Oral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder

Owner

• NextWave Pharmaceuticals, Inc., Monmouth Junction, NJ, US
• NextWave Pharmaceuticals, Inc., Cupertino, CA, US
• NextWave Pharmaceuticals, Inc., Cupertino, CA, US

Prosecution history

• 20 Apr 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
• 20 Apr 2023 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
• 20 Apr 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 20 Apr 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 07 Oct 2022 — TEAS SECTION 8 & 9 RECEIVED
• 27 Aug 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
• 26 Aug 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
• 26 Aug 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 26 Aug 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 16 Jul 2019 — TEAS SECTION 8 & 15 RECEIVED
• 05 Feb 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 05 Feb 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 03 Oct 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
• 27 Aug 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 27 Aug 2013 — REGISTERED-PRINCIPAL REGISTER